Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
When you’re looking to commercialize a product, compound, or technology, you need accurate and reliable pharmaceutical licensing deals data to inform your pharma licensing partnership. Whether you are in-licensing a product or out licensing your own intellectual property, backing your deal with the most current and comprehensive pharma licensing deals data is critical to your success. Where can you go to access the most accurate information to inform your pharma licensing activities?
Navigating the terrain of pharma licensing requires the proper tools, and Informa Pharma Intelligence provides them. Effectively support every aspect of your pharmaceutical licensing deal with the market data necessary to ensure you’re taking the right steps and making the right decisions. With Pharma Intelligence, you get the accurate data about pharmaceutical licensing, with data that reflects both historical deals data (like pharma licensing deals 2018) and current information about pharma licensing deal structures. View deal making from all angles, with exclusive data and expert analysis, only from Pharma Intelligence.
TrialScope Atlas
19 May 2022
Clinical trial disclosure is a complex process driven by a constantly evolving collection of registry rules and health authority regulations.
Topic Regulation
Topic Clinical Trials
TrialScope Disclose
13 May 2022
Clinical trial disclosure experts Francine Lane and Thomas Wicks provide an overview of EU CTR/CTIS regulations and timelines for compliance.
Topic Market Intelligence
13 May 2022
Based on a survey to over 100 of pharma’s senior decision makers, find out what organizations really want from CDMOs.
Pharma 360
13 May 2022
Join Informa Pharma Intelligence for the “Global Oncology Opportunities” webinar!
TrialScope Disclose
13 May 2022
Disclosure & transparency experts from Sarepta, Boehringer Ingelheim, Bayer and Merck KGaA discuss the ins and outs of CTIS.
Topic Regulation
Citeline, Pharmaprojects
By Ian Lloyd 14 Apr 2022
Our world was disrupted at warp speed during 2020. Are you ready to gain a deeper understanding of the year that changed our perceptions of possible?
Chemist + Druggist Data
11 Mar 2022
We are pleased to announce that from mid-February 2022, C+D Data will provide the UK supply chain with additional product listings and associated PIP-codes for Northern Ireland (NI) and Great Britain (GB.) This solution will allow you to reach the entire UK market quickly and facilitate the ordering and distribution of medicines without disruption to you, and your wholesalers – while ensuring the data’s accuracy, visibility, and long-term management.
In Vivo
02 Mar 2022
Look ahead with our Pharma Outlook 2022 Extract as we discuss what's coming up in the biopharma space.
Biomedtracker, Meddevicetracker
08 Feb 2022
In pharma’s fast paced and continually evolving world, accurately anticipating the impact of events on the horizon is critical to your success.
Topic Business Strategies
TrialScope Disclose
07 Feb 2022
Disclosure requirements are numerous and ever evolving. Study sponsors need a transparency policy that addresses disclosure, transparency, and data sharing.
Topic Policy & Regulation
Citeline
02 Feb 2022
In our rare disease trial strategies whitepaper, see which sponsors lead the way, understand the geographical location of trials, and delve into the types of therapeutic area, plus much more.
Topic Rare Diseases
Pink Sheet
By Bridget Silverman 19 Jan 2022
US FDA’s accelerated approvals hit a contemporary high in 2021, accounting for one-third of novel US approvals, but the big story was the agency’s crackdown on delinquent confirmatory trials for oncology AA indications.
Pink Sheet
By Vibha Sharma 18 Jan 2022
The EU will make it mandatory for clinical trial sponsors to prepare layperson summaries of their study results. Industry practices around content presentation, translation and dissemination of these documents will be keenly watched.
Scrip
23 May 2022
Generics Bulletin
23 May 2022
Medtech Insight
23 May 2022
In Vivo
23 May 2022
In Vivo
23 May 2022
In Vivo
23 May 2022
Scrip
23 May 2022
HBW Insight
23 May 2022
Medtech Insight
23 May 2022
Scrip
23 May 2022
Medtech Insight
23 May 2022
Scrip
23 May 2022
Pink Sheet
23 May 2022
Pink Sheet
23 May 2022
Pink Sheet
23 May 2022
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Speak to Sales
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Client Services
Contact us for product technical and account support.
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
